43 results
Page 2 of 3
8-K
EX-99.1
15uw6wlo
12 Jun 23
Regulation FD Disclosure
5:01pm
DEF 14A
u2idw814dqtpt6qutb
19 May 23
Definitive proxy
4:31pm
8-K
EX-99.2
a477zualjsov8e9jc9
16 May 23
Regulation FD Disclosure
7:47am
8-K
rkvco
16 May 23
Regulation FD Disclosure
7:47am
8-K
EX-99.1
40qxmo1m
16 May 23
Regulation FD Disclosure
7:47am
10-Q
EX-10.1
xn0pvcpnd5e3z
10 May 23
Quarterly report
7:14am
10-Q
po6bmhpra3zxspeix
10 May 23
Quarterly report
7:14am
8-K
EX-99.1
mslp2dwuz96pazd59
10 May 23
Coya Therapeutics, Inc. Provides Business Update and Reports Q1 2023 Unaudited Financial Results
7:11am
10-K/A
k2thlg7m jftnim
1 May 23
Annual report (amended)
5:12pm
10-K
inbqqd5
29 Mar 23
Annual report
4:08pm
424B4
qj2e4y7lfqn
30 Dec 22
Prospectus supplement with pricing info
4:17pm
CORRESP
5cuus1a 7vg5cq18
13 Dec 22
Correspondence with SEC
12:00am
FWP
fq6bf yi7k
6 Dec 22
Free writing prospectus
4:17pm
S-1/A
8saux37
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
EX-10.12
bw316dfkwnpi
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-10.12
oqhh wdlj
18 Nov 22
IPO registration
5:06pm
S-1
f4un645t5oqjxp2
18 Nov 22
IPO registration
5:06pm
DRS/A
xuumh
28 Oct 22
Draft registration statement (amended)
12:00am
DRSLTR
3njllv3v tm64
7 Oct 22
Correspondence regarding draft registration statement
12:00am